Alexandra Tolia

Engages in drug delivery and development services

Operates as a technology platform that develops mRNA and lipid nanoparticle therapeutics

Develops AI-driven simulation technology and related platform for clinical heart interventions

Researches, develops, manufactures and markets drugs for treatment and cancers and other diseases

Engages in research and development in biotechnology

Develops pharmaceutical products

Fund+ invests in companies located in Europe primarily in Belgium. The firm focuses on the life sciences primarily active in therapeutics, as well as companies developing diagnostics and medical devices.. It participates in early stage capital requirements with an investment of EUR 5 - 15 million. The firm acquires minority interest and takes a seat on the board of directors. It also makes co-investments and subsequent financing.

PMV invests in companies located in Belgium. The firm focuses on a broad range of sectors and industries. It participates in equity and debt in seed stage, early stage, late stage and growth stage transactions with an investment size up to EUR 20 million. It consider minority investments and also makes co-investments.

Hunza is a venture capital investor focused on sectors including biotechnology, pharmaceuticals, medical technology and medical services. They also invest in high-tech industries such as software, energy, environmental technology, Internet and media. The firm targets companies with high-value creation potential and leverages their business experience, knowledge and networks to turn them into market leaders. They invest across development stages in seed, startup and expansion financing. Hunza invests globally through shareholder loans, majority or significant minority equity participations, mezzanine and bridge financing. Their investments have included traditional Chinese medicine, oncology, drug delivery technology and minimally-invasive medical devices for heart surgery.